Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition
Nature2017Vol. 551(7679), pp. 247–250
Citations Over TimeTop 1% of 2017 papers
Matthew J. Hangauer, Vasanthi S. Viswanathan, Matthew J. Ryan, Dhruv Bole, John K. Eaton, Alexandre Matov, Jacqueline Galeas, Harshil Dhruv, Michael E. Berens, Stuart L. Schreiber, Frank McCormick, Michael T. McManus
Related Papers
- → Persisters and beyond: Mechanisms of phenotypic drug resistance and drug tolerance in bacteria(2013)211 cited
- → Drug resistance mechanisms of cancer stem-like cells and their therapeutic potential as drug targets(2019)24 cited
- → Antagonistic drug combinations that select against drug resistance: From bacteria to cancer(2007)16 cited
- → Strategies to Estimate And Improve Drug Tolerance in Anti-Drug Antibody Assays(2012)9 cited
- → Drug tolerance, persister cells and drug discovery.(2012)1 cited